Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Richard Klausner, Dietrich Stephan

Premium

Richard Klausner has been named senior vice president and chief medical officer at Illumina.

Klausner joins Illumina from the Column Group, a venture capital firm. He previously served as executive director for global health at the Bill and Melinda Gates Foundation and as director of the US National Cancer Institute from 1995 to 2001.

Klausner holds an MD from Duke Medical School.


Dietrich Stephan has been named chair of the department of human genetics at the University of Pittsburgh Graduate School of Public Health and will also serve as the associate director of the Institute for Personalized Medicine, a collaborative initiative between the University of Pittsburgh Schools of the Health Sciences and UPMC.

Stephan was most recently founder, president, and CEO of Silicon Valley Biosystems. He also co-founded personal genetics firm Navigenics. Prior to that, Stephan held a number of roles at the Translational Genomics Research Institute, including director of neurogenomics. He was also head of the NIH Neuroscience Microarray Consortium for seven years.

The Scan

Interfering With Invasive Mussels

The Chicago Tribune reports that researchers are studying whether RNA interference- or CRISPR-based approaches can combat invasive freshwater mussels.

Participation Analysis

A new study finds that women tend to participate less at scientific meetings but that some changes can lead to increased involvement, the Guardian reports.

Right Whales' Decline

A research study plans to use genetic analysis to gain insight into population decline among North American right whales, according to CBC.

Science Papers Tie Rare Mutations to Short Stature, Immunodeficiency; Present Single-Cell Transcriptomics Map

In Science this week: pair of mutations in one gene uncovered in brothers with short stature and immunodeficiency, and more.